As hospitals faced the onslaught of scared patients fearing they had Covid-19, some organizations tip-toed into artificial intelligence to help serve as a first line of defense. The impact may send AI into the hospital mainstream.
Many retailers faced major issues prior to the crisis, which has led to threats on their future with sales plummeting due to shelter-in-place orders. Now, as states reopen, how retailers respond could determine their survival.
Delaying new product launches has become one of the most popular strategic tactics companies have taken to stem losses from Covid-19. Even if your company is moving back to full operations, it doesn’t mean those new products should hit shelves soon.
Even as company workforces shelter in place, misconduct has suddenly ceased. Avoidance of investigating fraud or harassment could leave a company liable, even in the time of Covid.
Social distancing could become the new normal for months to come, until a vaccine develops. Here’s how some companies have adapted to these new rules.
As companies try to circumvent the pandemic, many have closed ranks around their CEO, whether they want to or not.
As companies try to return to normal business, they will also have another concern to protect themselves from: Lawsuits. From healthcare, to cruise lines to insurance, most industries will have to deal with an onslaught of litigation from customers, partners and investors.
Even as companies tip-toe back to full operations again, the threat of a second wave of Covid-19 spread remains high. Boards must use this window to make changes, in case the impact of the second wave is higher than the first.
Boards must prepare for when things begin returning to normal again. How a company bounces back from this devastation could determine its survival.
In the fallout of COVID-19, technology has become the one sector that has uniquely benefited from the isolated workforce and the need for novel medicine. But the reliance on tech, medical technology and biotechnology in this uncertain time has provided opportunities for non-tech firms to unite with tech and medical leaders as well.